Financials
- Market Capitalization 3.43 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-43.37
売上高対価格比率
7.34
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1577 | DNLI Denali Therapeutics Inc. - Common Stock | 22.65 USD | -14.46% | -13.15% | +2.40% | +40.07% | 3.59 B USD | ||
| 1582 | RCUS Arcus Biosciences, Inc. Common Stock | 28.34 USD | +0.93% | -5.03% | +16.00% | +208.04% | 3.56 B USD | ||
| 1616 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.78 USD | +0.59% | +1.62% | +26.96% | +1.58% | 3.40 B USD | ||
| 1627 | ALMS Alumis Inc. - Common Stock | 27.28 USD | -2.92% | -6.16% | +18.20% | +504.88% | 3.37 B USD |